St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Drug discovery & development tools
- ARF and HDM2 interaction domains (SJ-01-0016)
- Alternate mTOR Pathway (SJ-09-0021)
- Assay for ATM Kinase Modulation (SJ-02-0008)
- BMP Compounds for treating diseases caused by defective or diminished BMP signaling (Medulloblastoma) - (SJ-15-0008)
- Caspase 1 inhibition (SJ-13-0039)
- Cells That Lack p19Ink4d and p27Kip1 Activity/p19Ink4d and p27Kip1 Null Mice (SJ-98-0023)
- Chimeric gene and protein generated Optogranules: Light induced stress granules (SJ-18-0010)
- DCN1 Inhibitors (SJ-16-0002)
- Defects in LC3-associated phagocytosis (LAP) associated with lupus (SJ-16-0025)
- Diagnosing and treating learning or mental disorders with SERCA2 protein and miRNAs (SJ-10-0003, SJ-12-0020)
- Discovery of a fluorescent vinblastine analog with high affinity to the human pregnane X receptor (hPXR) Ligand (SJ-13-0009)
- Discovery of a novel inhibitor of constitutive androstane receptor (CAR) that does not activate pregnane X receptor (PXR) (SJ-14-0039)
- EP300 and CBP Binding Compounds (SJ-23-0032)
- FRET assay for G3BP1 and G3BP2 inhibitors (SJ-19-0043)
- Hematopoietic progenitor cell lines with myeloid and lymphoid potential (SJ-11-0003)
- Identification of Toll-like receptor signaling inhibitors (SJ-18-0008)
- Inhibiting Mir-451 to treat Beta-Thalassemia (SJ-20-0030)
- Interaction of Reelin With Very Low Density Lipoprotein (VLDL) Receptor (SJ-98-0045)
- LANDO pathway disruption for Alzheimer's disease (SJ-19-0020)
- Method for Enhancing Recombinant Antibody Production (SJ-08-0032)
- Modulating non-canonical autophagy (LAP) in myeloid cells to suppress tumors (SJ-17-0019)
- NLRP12 Activators and Screening Tool (SJ-23-0016)
- Neurokinin-1 receptor antagonists as antifungal enhancers (SJ-21-0021)
- Ozz, A Protein That Regulates Development and Function of Muscle Cells (SJ-99-0010)
- Plate stage for drug screening systems (SJ-22-0031)
- Preventing and treating hearing loss using CDK2 inhibitors (SJ-14-0028)
- Rapid cloning of T cell receptors (SJ-16-0001)
- Regulating p53 translation and function (SJ-05-0002)
- Respiratory cell isolation and propagation for pathogen study (SJ-18-0028)
- SCCRO peptide inhibitor (SJ-11-0014)
- Small molecule BODIPY FL VH032 probe for E3 ligase (SJ-21-0014)
- Specific retinoid receptor agonists and antagonists for cancer (SJ-14-0011)
- miRNAs for treating cerebral ventricle enlargement in schizophrenia patients (SJ-19-0039)
For more information
Contact the Office of Technology Licensing:
Phone: (901) 595-2342
Fax: (901) 595-3148